Low-molecular-weight heparins (LMWH) enoxaparin (Lovenox, J1650), dalteparin (Fragmin, J1645), fondaparinux (Arixtra, J1652) Oral anticoagulation (DOACs Direct Oral Anticoagulants): Rivaroxaban (Xarelto), apixaban (Eliquis), dabigatran (Pradaxa), edoxaban (Savaysa) reported via NDC on Medicare Part D claims Vitamin K antagonist: Warfarin (Coumadin) oral, Part D NDC
However, many of these medications have significant side effects or are only recommended for patients who meet certain criteria, so they arent for everyone
Recognizing early signs of adverse effects and when to seek medical help
top of page Tirzepatide Tirzapatide is a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist
This post digs deep into the latest real-world data, safety signals and market dynamics shaping GLP-1 therapies
The evergreening playbook: How pharma extends drug exclusivity and what it actually costs